2-Aminoacridone

CAS No. 27918-14-5

2-Aminoacridone( —— )

Catalog No. M24191 CAS No. 27918-14-5

2-Aminoacridone is a widely used fluorophore (λexc=428 nm, λem=525 nm).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 38 In Stock
5MG 58 In Stock
10MG 88 In Stock
25MG 158 In Stock
50MG 237 In Stock
100MG 356 In Stock
200MG 534 In Stock
500MG 854 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    2-Aminoacridone
  • Note
    Research use only, not for human use.
  • Brief Description
    2-Aminoacridone is a widely used fluorophore (λexc=428 nm, λem=525 nm).
  • Description
    2-Aminoacridone is a widely used fluorophore (λexc=428 nm, λem=525 nm).
  • In Vitro
    By using 2-Aminoacridone (AMAC) as labeling molecule, sensitivity for detection of GAG-derived disaccharides is greatly enhanced, and resolution is also improved.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    27918-14-5
  • Formula Weight
    210.23
  • Molecular Formula
    C13H10N2O
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 2.94 mg/mL (13.98 mM)
  • SMILES
    Nc(cc1)cc2c1Nc(cccc1)c1C2=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Robert A. M. Vreeburg,et al. Fingerprinting of hydroxyl radical-attacked polysaccharides by N-isopropyl-2-aminoacridone labelling.Biochem J. 2014 Oct 15; 463(Pt 2): 225–237.
molnova catalog
related products
  • Temoporfin

    Temoporfin used in photodynamic therapy for the treatment of squamous cell carcinoma of the head and neck.

  • 8-Oxoepiberberine

    8-Oxoepiberberine is an alkaloid metabolite in the plasma after oral administration of Zuojin formula, a traditional chinese medicine used to treat gastrointestinal disease.

  • kaempferide

    Kaempferide triglycoside inhibits the proliferation of native and estrogen receptor beta overexpressing colon cancer cells through a mechanism not mediated by ligand binding dependent estrogen receptor activation.